Regulus Therapeutics
RGLS
#8357
Rank
NZ$0.28 B
Marketcap
$4.26
Share price
9.91%
Change (1 day)
12.01%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -NZ$76.88 Million

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -NZ$49.22 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$77.26 Million56.97%
2023 -NZ$49.22 Million6.51%
2022 -NZ$46.21 Million2.53%
2021 -NZ$45.07 Million93.59%
2020 -NZ$23.28 Million-15.41%
2019 -NZ$27.52 Million-64.46%
2018 -NZ$77.43 Million-33.26%
2017 -NZ$0.12 Billion-13.98%
2016 -NZ$0.14 Billion44.77%
2015 -NZ$93.17 Million-1.63%
2014 -NZ$94.71 Million203.6%
2013 -NZ$31.2 Million8.65%
2012 -NZ$28.71 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$7.34 B-9,611.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$13.27 B-17,290.56%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$3.18 B-4,225.54%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.44 B-22,682.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
-NZ$0.4 Billion 409.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.17 Billion 113.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$14.02 Billion 18,036.36%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.2 Billion 154.66%๐Ÿ‡บ๐Ÿ‡ธ USA